BN Stock Analysis: Brookfield | NYSE
Asset Management | NYSE, USA | Market Cap: 82.218m USD | 12M Return: -17% | CA11271J1075 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 193M
EPS Trend: 4.5%
Qual. Beats: 0
Rev. Trend: -92.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brookfield Corporation (NYSE: BN) is a large-cap, Canada-based multi-asset manager operating within the GICS Financials sector (Asset Management & Custody Banks sub-industry). The firm invests across real estate, credit, renewable power and transition, infrastructure, venture capital, and private equity, deploying both its own capital and third-party capital from institutional and retail clients. Its investment approach targets sizeable, premier assets globally, with a geographic emphasis on North America (including the U.S., Canada, and Brazil), Europe, Australia, the Middle East and North Africa, and Asia-Pacific.
Within private equity and venture capital, Brookfield pursues acquisitions, control and distressed buyouts, corporate carve-outs, recapitalizations, and various forms of debt and equity financing, including turnarounds of underperforming midmarket companies. Sector focus spans business services (such as infrastructure, healthcare, and road fuel distribution), industrials (including automotive batteries, graphite electrodes, and smart cards), and residential and infrastructure services. The firm also provides business process outsourcing, financial services, software and technology services, and real estate-related services, while actively investing in the energy transition and targeting companies with underlying real assets in areas like industrial products, building materials, mining, oil and gas, and manufacturing.
- Insurance Solutions growth drives fee-related earnings higher
- Renewable power segment expands amid accelerating energy transition demand
- Asset management AUM scales with flagship private fund deployments
- Commercial real estate refinancing risks pressure private equity returns
| Net Income: 1.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -1.53 > 1.0 |
| NWC/Revenue: 11.83% < 20% (prev -13.41%; Δ 25.24% < -1%) |
| CFO/TA 0.02 > 3% & CFO 9.27b > Net Income 1.42b |
| Net Debt (258b) to EBITDA (33.4b): 7.73 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.37b) vs 12m ago 0.34% < -2% |
| Gross Margin: 28.76% > 18% (prev 31.50%; Δ -2.73% > 0.5%) |
| Asset Turnover: 15.08% > 50% (prev 15.03%; Δ 0.05% > 0%) |
| Interest Coverage Ratio: 1.31 > 6 (EBIT TTM 22.8b / Interest Expense TTM 17.3b) |
| A: 0.02 (Total Current Assets 72.9b - Total Current Liabilities 63.7b) / Total Assets 526b |
| B: 0.03 (Retained Earnings 16.2b / Total Assets 526b) |
| C: 0.04 (EBIT TTM 22.8b / Avg Total Assets 516b) |
| D: 0.13 (Book Value of Equity 46.6b / Total Liabilities 359b) |
| Altman-Z'' = 0.65 = B |
| DSRI: 2.15 (Receivables 48.6b/22.1b, Revenue 77.8b/76.1b) |
| GMI: 1.10 (GM 31.50% / 28.76%) |
| AQI: 0.70 (AQ_t 0.39 / AQ_t-1 0.55) |
| SGI: 1.02 (Revenue 77.8b / 76.1b) |
| TATA: -0.01 (NI 1.42b - CFO 9.27b) / TA 526b) |
| Beneish M = -2.15 (Cap -4..+1) = BB |
As of October 12, 2026, the stock is trading at USD 37.09 with a total of 3,839,002 shares traded. Over the past week, the price has changed by +0.46%, over one month by -3.54%, over three months by -13.77% and over the past year by -17.03%.
Current recommended Stop Loss: 35.60 (which is 4% or 2 ATR below the current price).
Brookfield has received a consensus analysts rating of 4.18. Therefore, it is recommended to buy BN.
- StrongBuy: 5
- Buy: 5
- Hold: 0
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 54.3 | 46.3% |
P/E Trailing = 68.2037
P/E Forward = 11.8906
P/S = 1.0189
P/B = 1.949
P/EG = 1.2722
Revenue TTM = 77.8b USD
EBIT TTM = 22.8b USD
EBITDA TTM = 33.4b USD
Long Term Debt = 222b USD (from longTermDebt, last quarter)
Short Term Debt = 28.4b USD (from shortTermDebt, last quarter)
Debt = 273b USD (from shortLongTermDebtTotal, last quarter) + Leases 8.22b
Net Debt = 258b USD (calculated: Debt 273b - CCE 14.9b)
Enterprise Value = 341b USD (82.2b + Debt 273b - CCE 14.9b)
Interest Coverage Ratio = 1.31 (Ebit TTM 22.8b / Interest Expense TTM 17.3b)
EV/FCF = -36.64x (Enterprise Value 341b / FCF TTM -9.29b)
FCF Yield = -2.73% (FCF TTM -9.29b / Enterprise Value 341b)
FCF Margin = -11.95% (FCF TTM -9.29b / Revenue TTM 77.8b)
Net Margin = 1.82% (Net Income TTM 1.42b / Revenue TTM 77.8b)
Gross Margin = 28.76% ((Revenue TTM 77.8b - Cost of Revenue TTM 55.4b) / Revenue TTM)
Gross Margin QoQ = 10.66% (prev 24.10%)
Tobins Q-Ratio = 0.65 (Enterprise Value 341b / Total Assets 526b)
Interest Expense / Debt = 6.35% (Interest Expense 17.3b / Debt 273b)
Taxrate = 26.68% (1.34b / 5.02b)
NOPAT = 16.7b (EBIT 22.8b * (1 - 26.68%))
Current Ratio = 1.14 (Total Current Assets 72.9b / Total Current Liabilities 63.7b)
Debt / Equity = 5.87 (Debt 273b / totalStockholderEquity, last quarter 46.6b)
Debt / EBITDA = 7.73 (Net Debt 258b / EBITDA 33.4b)
Debt / FCF = -27.79 (negative FCF - burning cash) (Net Debt 258b / FCF TTM -9.29b)
Total Stockholder Equity = 47.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.27% (Net Income 1.42b / Total Assets 526b)
RoE = 3.02% (Net Income TTM 1.42b / Total Stockholder Equity 47.0b)
RoCE = 8.47% (EBIT 22.8b / Capital Employed (Equity 47.0b + L.T.Debt 222b))
RoIC = 3.44% (NOPAT 16.7b / Invested Capital 486b)
WACC = 6.18% (E(82.2b)/V(355b) * Re(11.24%) + D(273b)/V(355b) * Rd(6.35%) * (1-Tc(0.27)))
Discount Rate = 11.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 71.14 | Cagr: 0.98%
[DCF] Fair Price = unknown (Cash Flow -9.29b)
EPS Correlation: 4.50 | EPS CAGR: 2.28% | SUE: 0.04 | # QB: 0
Revenue Correlation: -92.13 | Revenue CAGR: -10.22% | SUE: 0.70 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=2.87 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+0.0% | GrowthRev=+12.9%
EPS next Year (2027-12-31): EPS=3.51 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+22.3% | GrowthRev=+35.3%